Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Obesity

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    April 2025
  1. GRIBSHOLT SB, Farkas DK, Jepsen P, Richelsen B, et al
    Overweight/Obesity and Gastrointestinal Disease Incidence in Denmark-A Cohort Study.
    Eur J Endocrinol. 2025 Apr 10:lvaf077. doi: 10.1093.
    PubMed     Abstract available


    March 2025
  2. CASTERAS A, Fidilio E, Comas M, Zabalegui A, et al
    Impaired accuracy of the dexamethasone suppression test after bariatric surgery: implications for post-surgical cortisol interpretation.
    Eur J Endocrinol. 2025;192:346-355.
    PubMed     Abstract available


  3. GAMBINERI A, Rosa S, Pandurevic S, Cecchetti C, et al
    Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome.
    Eur J Endocrinol. 2025;192:210-219.
    PubMed     Abstract available


    February 2025
  4. KAHVECI A, Kurt I, Turan S, Guran T, et al
    Real-life experience on efficacy and safety of setmelanotide treatment in prepubertal children.
    Eur J Endocrinol. 2025;192:K15-K18.
    PubMed     Abstract available


  5. BRACHS S, Soll D, Beer F, Huckauf N, et al
    Hormonal regulation of human adipose tissue lipolysis: impact of adipose GIP system in overweight and obesity.
    Eur J Endocrinol. 2025;192:91-99.
    PubMed     Abstract available


    November 2024
  6. MILLER C, Madden-Doyle L, Jayasena C, McIlroy M, et al
    Mechanisms in endocrinology: hypogonadism and metabolic health in men-novel insights into pathophysiology.
    Eur J Endocrinol. 2024;191:R1-R17.
    PubMed     Abstract available


    September 2024
  7. PADILLA C, Stratakis CA, Tatsi C
    The phenotype of the pediatric patient with Cushing syndrome but without obesity.
    Eur J Endocrinol. 2024 Sep 17:lvae114. doi: 10.1093.
    PubMed     Abstract available


    August 2024
  8. LECOQ AL, Schilbach K, Rocher L, Trabado S, et al
    Metabolically healthy obesity in adults with X-linked hypophosphatemia.
    Eur J Endocrinol. 2024;191:156-165.
    PubMed     Abstract available


    July 2024
  9. TRUEBA-TIMMERMANS DJ, Grootjen LN, Kerkhof GF, Rings EHHM, et al
    Thyroid hormone levels in children with Prader-Willi Syndrome: A randomized controlled Growth Hormone (GH)-trial and 10-year GH study.
    Eur J Endocrinol. 2024 Jul 25:lvae088. doi: 10.1093.
    PubMed     Abstract available


  10. WINCKELMANN LA, Gribsholt SB, Bodkergaard K, Rejnmark L, et al
    Risk of fractures following bariatric surgery with Roux-en-Y gastric bypass or sleeve gastrectomy: a Danish population-based cohort study.
    Eur J Endocrinol. 2024;191:1-8.
    PubMed     Abstract available


  11. KWOK TC, Ramage LE, Kelman A, Suchacki KJ, et al
    UCP1 expression in human brown adipose tissue is inversely associated with cardiometabolic risk factors.
    Eur J Endocrinol. 2024;191:106-115.
    PubMed     Abstract available


    March 2024
  12. VAN BEIJSTERVELDT IALP, van Zelst BD, Dorrepaal DJ, van den Berg SAA, et al
    Early life poly- and perfluoroalkyl substances (PFAS) levels and adiposity in the first 2 years of life.
    Eur J Endocrinol. 2024 Mar 30:lvae039. doi: 10.1093.
    PubMed     Abstract available


  13. GATTA-CHERIFI B, Mohammedi K, Cariou T, Poitou C, et al
    Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
    Eur J Endocrinol. 2024 Mar 7:lvae024. doi: 10.1093.
    PubMed     Abstract available


    February 2024
  14. FERNANDEZ-GARCIA P, Taxeras SD, Reyes-Farias M, Gonzalez L, et al
    Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis and cell differentiation.
    Eur J Endocrinol. 2024 Feb 20:lvae018. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  15. LEE J, Jung JH, Kim J, Jeong C, et al
    Associations between body composition and the risk of fracture according to bone mineral density in postmenopausal women: a population-based database cohort study.
    Eur J Endocrinol. 2023;189:527-536.
    PubMed     Abstract available


    October 2023
  16. GATTA-CHERIFI B, Laboye A, Gronnier C, Monsaingeon-Henry M, et al
    A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery.
    Eur J Endocrinol. 2023;189:K15-K18.
    PubMed     Abstract available


  17. PLUIMAKERS VG, van Atteveld JE, de Winter DTC, Bolier M, et al
    Prevalence, risk factors and optimal way to determine overweight, obesity and morbid obesity, in the first Dutch cohort of 2,338 long-term survivors of childhood cancer: a DCCSS-LATER study.
    Eur J Endocrinol. 2023 Oct 14:lvad139. doi: 10.1093.
    PubMed     Abstract available


    August 2023
  18. JONES TH, Dobs AS, Randeva H, Moore W, et al
    Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind Randomised Controlled Trial.
    Eur J Endocrinol. 2023 Aug 14:lvad099. doi: 10.1093.
    PubMed     Abstract available


  19. INDER WJ, Grossmann M
    Obesity and 'functional hypogonadism' - mechanisms and management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT".
    Eur J Endocrinol. 2023 Aug 7:lvad100. doi: 10.1093.
    PubMed    


    July 2023
  20. TRUEBA-TIMMERMANS DJ, Grootjen LN, Juriaans AF, Mahabier EF, et al
    Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
    Eur J Endocrinol. 2023;189:132-139.
    PubMed     Abstract available


  21. OLLILA MM, Hoek A, Piltonen TT
    The association between polycystic ovary syndrome and early cardiovascular disease morbidity strengthens.
    Eur J Endocrinol. 2023;189:R4-R5.
    PubMed    


  22. SIMCHONI M, Derazne E, Pinhas-Hamiel O, Cukierman-Yaffe T, et al
    Adolescent body mass index and cognitive performance: a nationwide study of 2.48 million Israeli adolescents.
    Eur J Endocrinol. 2023;188:630-640.
    PubMed     Abstract available


    June 2023
  23. EZQUERRO S, Tuero C, Becerril S, Valenti V, et al
    Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated NAFLD.
    Eur J Endocrinol. 2023 Jun 26:lvad071. doi: 10.1093.
    PubMed     Abstract available


  24. DWIVEDI AK, Vishwakarma D, Dubey P, Reddy S, et al
    Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
    Eur J Endocrinol. 2023;188:555-563.
    PubMed     Abstract available


    April 2023
  25. CANNARELLA R, Caruso M, Condorelli RA, Timpanaro TA, et al
    Testicular volume in 268 children and adolescents followed-up for childhood obesity-a retrospective cross-sectional study.
    Eur J Endocrinol. 2023;188:331-342.
    PubMed     Abstract available


    March 2023
  26. SONNEFELD L, Rohmann N, Geisler C, Laudes M, et al
    Is human obesity an inflammatory disease of the hypothalamus?
    Eur J Endocrinol. 2023 Mar 8:lvad030. doi: 10.1093.
    PubMed     Abstract available


  27. BECKHAUS J, Friedrich C, Boekhoff S, Calaminus G, et al
    Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage.
    Eur J Endocrinol. 2023;188:lvad027.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.